Keyphrases
5-year Survival
25%
Advanced Stage
25%
Advanced Stage Disease
25%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
100%
Cancer Registry
25%
Chemotherapy
75%
Confidence Interval
75%
Cyclophosphamide
25%
Doxorubicin
25%
Enteropathy-associated T-cell Lymphoma
100%
Etoposide
75%
Hazard Ratio
75%
Limited-stage
25%
Lymphoma Patients
50%
Netherlands
100%
Overall Survival
100%
Period Analysis
25%
Peripheral T-cell Lymphoma
50%
Poor Prognosis
25%
Population-based Cohort Study
100%
Predictors of Poor Prognosis
25%
Prednisone
25%
Primary Therapy
25%
Medicine and Dentistry
Autologous Stem Cell Transplantation
80%
Cancer Registry
20%
CHOP
20%
Cohort Analysis
100%
Cyclophosphamide
20%
Diseases
20%
Doxorubicin
20%
Enteropathy-Associated T-Cell Lymphoma
100%
Etoposide
60%
Hazard Ratio
60%
Overall Survival
100%
Peripheral T-Cell Lymphoma
40%
Prednisone
20%
Vincristine
20%
Pharmacology, Toxicology and Pharmaceutical Science
Cancer Registry
20%
Chemotherapy
60%
Cohort Study
100%
Cyclophosphamide
20%
Diseases
20%
Doxorubicin
20%
Enteropathy Associated T Cell Lymphoma
100%
Etoposide
60%
Overall Survival
100%
Peripheral T Cell Lymphoma
40%
Prednisone
20%
Vincristine
20%